US Patent Issued to Pfizer on March 17 for "Antiviral heteroaryl ketone derivatives" (Massachusetts, Connecticut Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,240, issued on March 17, was assigned to Pfizer Inc. (New York).

"Antiviral heteroaryl ketone derivatives" was invented by Dafydd Rhys Owen (Concord, Mass.), Martin Youngjin Pettersson (Littleton, Mass.), Matthew Richard Reese (Mystic, Conn.), Matthew Forrest Sammons (Quincy, Mass.), Jamison Bryce Tuttle (Marblehead, Mass.) and Qingyi Yang (Lexington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to compounds of Formula Iwherein R1, R2, p, m, A, Z1, Z2, Z3 and Z4 are as defined herein, pharmaceutical compositions comprising the compounds, methods of treating COVID-19 in a patient by administering therapeutically effecti...